Answers are grounded in this paper and cite their sources.
Early and precise identification of Cardiovascular Diseases (CVDs) is crucial to preventing patients from suffering permanent damage or death, prompting the development of immunosensor devices to detect and measure cardiac biomarkers.
No takes yet. Share an insight, caveat, or question.
Dutra RF (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: